Molecules 2013, 18
1445
2
2
5. Birendra, N.G.; Jiban, C.S.K.; Jogendra, N.B. Quinoline-based fused heterocyclic systems are
found as potential anticancer. J. Heterocycl. Chem. 1984, 21, 1225–1229.
6. Kothari, P.J.; Mehlhoff, M.A.; Singh, S.P.; Parmar, S.S.; Stenberg, V.I. Synthesis of some new
5
-methyl-2-benzoxazolinone derivatives and investigation on their analgesic-antiinflammatory
activities. J. Heterocycl. Chem. 1980, 17, 1369–1372.
2
2
2
3
7. Sengupta, A.K.; Misra, H.K. Studies on potential pesticides 13 Synthesis and evaluation of s-(3-
substituted-phenoxymethyl-4-aryl/cyclohexyl-4h-1,2,4-triazol-5-yl)-2-mercaptomethyl
benzimidazoles for anti-bacterial and insecticidal activities. J. Indian Chem. Soc. 1981, 8, 508.
8. Sarmah, S.C.; Bahel, S.C. Synthesis of aryloxy/aryl acetyl thiosemicarbazides, substituted 1,3,4-
oxadiazoles, 1,3,4-thiadiazoles, 1,2,4-triazoles and related compounds as potential fungicides.
J. Indian Chem. Soc. 1982, 59, 877–880.
9. Francis, J.E.; Cash, W.D.; Psychoyos, S.; Ghai, G.; Wenk, P.; Friedmann, R.C.; Atkins, C.; Warren,
V.; Furness, P.; Hyun, T.L.; et al. Structure-activity profile of a series of novel triazoloquinazoline
adenosine antagonists. J. Med. Chem. 1988, 31, 1014–1020.
0. Kim, Y.-C.; De Zwart, M.; Chang, L.; Moro, S.; Kuenzel, J.; Melman, N.; Jzerman, A.P.;
Jacobson, K.A. Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) having
high potency at the human A2B and A3 receptor subtypes. J. Med. Chem. 1998, 41, 2835–2845.
1. Ongini, E.; Monoppoli, A.; Cacciari, B.; Baraldi, P.G. Selective adenosine A2A receptor
antagonists. Il Farmaco 2001, 56, 87–90.
3
3
2. Francis, J.E.; Cash, W.D.; Barbaz, B.S.; Bernard, P.S.; Lovell, R.A.; Mazzenga, G.C.;
Friedmann, R.C.; Hyun, J.L.; Braunwalder, A.F.; Loo, P.S.; et al. Synthesis and benzodiazepine
binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-ones. J. Med. Chem.
1
991, 34, 281–290.
3
3. Alagarsamy, V.; Giridhar, R.; Yadav, M.R. Synthesis and pharmacological investigation of
novel 1-substituted-4-phenyl-1,2,4-triazolo[4,3-a]quinazolin-5(4H)-ones as a new class of
H1-antihistaminic agents. Bioorg. Med. Chem. Lett. 2005, 15, 1877–1880.
3
4. Alagarsamy, V.; Solomon, V.R.; Murugan, M. Synthesis and pharmacological investigation of
novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of
H1-antihistaminic agents. Bioorg. Med. Chem. 2007, 15, 4009–4015.
3
5. Al-Salahi, R.; Geffken, D.; Koellner, M. A new series of 2-Alkoxy(aralkoxy)-[1,2,4]triazolo[1,5-
a]quinazolin-5-ones as Adenosine Receptor Antagonists. Chem. Pharm. Bull. 2011, 59, 730–733.
6. Al-Salahi, R.; Geffken, D. Synthesis of novel 2-alkoxy(aralkoxy)-4H-[1,2,4]triazolo[1,5-
a]quinazolin-5-ones starting with dialkyl-N-cyanoimidocarbonates. J. Heterocycl. Chem. 2011,
3
4
8, 656–662.
3
3
3
4
7. Al-Salahi, R.; Geffken D. Novel synthesis of 2-alkoxy(aralkoxy)-5-chloro[1,2,4]-triazolo[1,5-
a]quinazoline and their derivatives. Heterocycles 2010, 81, 1843–1859.
8. Al-Salahi, R. Synthesis and reactivity of [1,2,4]triazolo-annelated quinazolines. Molecules 2010,
1
5, 7016–7034.
9. Jantova, S.; Ovadekova, R.; Letasiova, S.; Spirkova, K.; Stankovsky, S. Anti-microbial activity of
some substituted triazoloquinazolines. Folia Microbiol. 2005, 50, 90–94.
0. Al-Omary, M.F.; Abou-zeid, L.A.; Nagi, M.N.; Habib, E.E.; Abdel-Aziz, A.; El-Azab, A.S.;
Abdel-Hamide, S.G.; Al-Omar, M.A.; Al-Obaid, A.M.; El-Subbagh, H.I. Non-classical